ECOG-ACRIN Cancer Research Group
@eaonc.bsky.social
Biomarker-driven medical research involving adults who have or are at risk of developing cancer
The Fall 2025 Group Meeting session recordings are now available on the Attendee Hub Website.
Simply log in with your first name, last name, and the email address you used during registration ➡️ cvent.me/EvkYal #EAOnc
Simply log in with your first name, last name, and the email address you used during registration ➡️ cvent.me/EvkYal #EAOnc
October 29, 2025 at 6:40 PM
The Fall 2025 Group Meeting session recordings are now available on the Attendee Hub Website.
Simply log in with your first name, last name, and the email address you used during registration ➡️ cvent.me/EvkYal #EAOnc
Simply log in with your first name, last name, and the email address you used during registration ➡️ cvent.me/EvkYal #EAOnc
Day 2 of the #EAOnc Fall 2025 Group Meeting is underway! Let us know which sessions you are heading to today. And don’t miss our General Session at 5:30 PM! 🩺🩻📈
October 23, 2025 at 2:20 PM
Day 2 of the #EAOnc Fall 2025 Group Meeting is underway! Let us know which sessions you are heading to today. And don’t miss our General Session at 5:30 PM! 🩺🩻📈
Thank you to the exceptional presenters and panelists who helped make the Fall 2025 Comis #TranslationalScience Symposium a success: Drs. Jon Steingrimsson, @rhubbbstat.bsky.social, Paul Catalano, Walter Witschey, @jordanberlin5.bsky.social, & Mary Lou Smith!
October 22, 2025 at 8:49 PM
Thank you to the exceptional presenters and panelists who helped make the Fall 2025 Comis #TranslationalScience Symposium a success: Drs. Jon Steingrimsson, @rhubbbstat.bsky.social, Paul Catalano, Walter Witschey, @jordanberlin5.bsky.social, & Mary Lou Smith!
The Comis #TranslationalScience Symposium continues with talks by Dr. Paul Catalano of @danafarber.bsky.social @hsph.harvard.edu & Dr. Walter Witschey @pennmedicine.bsky.social. #AI #imaging
October 22, 2025 at 8:01 PM
The Comis #TranslationalScience Symposium continues with talks by Dr. Paul Catalano of @danafarber.bsky.social @hsph.harvard.edu & Dr. Walter Witschey @pennmedicine.bsky.social. #AI #imaging
First up: talks from Dr. Jon Steingrimsson & Dr. @rhubbbstat.bsky.social, both of @brownbiostatistics.bsky.social, on #AI, #MachineLearning, & #RealWorldData in cancer #ClinicalTrials. More to come!
October 22, 2025 at 7:32 PM
First up: talks from Dr. Jon Steingrimsson & Dr. @rhubbbstat.bsky.social, both of @brownbiostatistics.bsky.social, on #AI, #MachineLearning, & #RealWorldData in cancer #ClinicalTrials. More to come!
Group Co-Chair Dr. Mitch Schnall of @pennmedicine.bsky.social kicks off the Fall 2025 Robert L. Comis Translational Science Symposium, focused on #AI, #RealWorldData, and alternative approaches to phase 2 and 3 therapeutic questions. #EAOnc
October 22, 2025 at 7:15 PM
Group Co-Chair Dr. Mitch Schnall of @pennmedicine.bsky.social kicks off the Fall 2025 Robert L. Comis Translational Science Symposium, focused on #AI, #RealWorldData, and alternative approaches to phase 2 and 3 therapeutic questions. #EAOnc
The Robert L. Comis, MD Translational Science Symposium on Approaches Using #AI and Other Electronic Methods in #ClinicalTrials is underway. Join us in Salon E, 5th Floor! #EAOnc #CancerResearch
October 22, 2025 at 7:09 PM
The Robert L. Comis, MD Translational Science Symposium on Approaches Using #AI and Other Electronic Methods in #ClinicalTrials is underway. Join us in Salon E, 5th Floor! #EAOnc #CancerResearch
Congratulations to the Fall 2025 Edith Peterson Mitchell, MD Travel Scholars! #CancerResearch #ClinicalTrials #EAOnc
October 22, 2025 at 6:03 PM
Congratulations to the Fall 2025 Edith Peterson Mitchell, MD Travel Scholars! #CancerResearch #ClinicalTrials #EAOnc
Congratulations to the early-career researchers selected to present at our annual Young Investigator Symposium! 🩻🩺📈#EAOnc
October 22, 2025 at 3:54 PM
Congratulations to the early-career researchers selected to present at our annual Young Investigator Symposium! 🩻🩺📈#EAOnc
The #EAOnc Fall 2025 Group Meeting officially begins today! Looking forward to seeing you in Philadelphia. Check in at the registration desk on the 5th floor before heading to your first session. 🩺🩻📈
October 22, 2025 at 1:00 PM
The #EAOnc Fall 2025 Group Meeting officially begins today! Looking forward to seeing you in Philadelphia. Check in at the registration desk on the 5th floor before heading to your first session. 🩺🩻📈
You may be eligible to participate in a #PancreaticCancer study, EA2192/APOLLO, for patients with #PancreaticCancer that has been surgically removed and has a BRCA1, BRCA2, or PALB2 mutation. Learn more: bit.ly/apollo-trial #pancsm
October 1, 2025 at 4:17 PM
You may be eligible to participate in a #PancreaticCancer study, EA2192/APOLLO, for patients with #PancreaticCancer that has been surgically removed and has a BRCA1, BRCA2, or PALB2 mutation. Learn more: bit.ly/apollo-trial #pancsm
We congratulate Dr. Anthony Letai on his appointment as NCI Director. His deep scientific expertise & reputation as a collaborative leader make him an excellent choice to drive progress against #cancer. We look forward to working with him! #CancerResearch #ClinicalTrials
September 30, 2025 at 4:45 PM
We congratulate Dr. Anthony Letai on his appointment as NCI Director. His deep scientific expertise & reputation as a collaborative leader make him an excellent choice to drive progress against #cancer. We look forward to working with him! #CancerResearch #ClinicalTrials
Today is #WorldCancerResearchDay! Catch up on the latest
@eaonc.bsky.social research highlights from our August newsletter here ➡️https://bit.ly/aug25research #EAOnc #CancerResearch
@eaonc.bsky.social research highlights from our August newsletter here ➡️https://bit.ly/aug25research #EAOnc #CancerResearch
September 24, 2025 at 4:26 PM
Today is #WorldCancerResearchDay! Catch up on the latest
@eaonc.bsky.social research highlights from our August newsletter here ➡️https://bit.ly/aug25research #EAOnc #CancerResearch
@eaonc.bsky.social research highlights from our August newsletter here ➡️https://bit.ly/aug25research #EAOnc #CancerResearch
Today is the 2025 Rally for Medical Research! #RallyForNIH unites patients, survivors, researchers & advocates urging Congress to make National Institutes of Health funding a national priority.
Join us in calling for sustained, robust NIH support. Important info➡️ rallyformedicalresearch.org
Join us in calling for sustained, robust NIH support. Important info➡️ rallyformedicalresearch.org
September 18, 2025 at 4:19 PM
Today is the 2025 Rally for Medical Research! #RallyForNIH unites patients, survivors, researchers & advocates urging Congress to make National Institutes of Health funding a national priority.
Join us in calling for sustained, robust NIH support. Important info➡️ rallyformedicalresearch.org
Join us in calling for sustained, robust NIH support. Important info➡️ rallyformedicalresearch.org
ICYMI: Check out our round-up of recently published
@eaonc.bsky.social research results. More here ➡️ bit.ly/aug25research #EAOnc
@eaonc.bsky.social research results. More here ➡️ bit.ly/aug25research #EAOnc
September 10, 2025 at 4:23 PM
ICYMI: Check out our round-up of recently published
@eaonc.bsky.social research results. More here ➡️ bit.ly/aug25research #EAOnc
@eaonc.bsky.social research results. More here ➡️ bit.ly/aug25research #EAOnc
September is #ProstateCancerAwarenessMonth 💙. This month, we’re spotlighting EA8191/INDICATE, a #ClinicalTrial treating #ProstateCancer that has come back after surgery with apalutamide and targeted radiation based on PET imaging. More here: bit.ly/indicate-trial
September 10, 2025 at 2:39 PM
September is #ProstateCancerAwarenessMonth 💙. This month, we’re spotlighting EA8191/INDICATE, a #ClinicalTrial treating #ProstateCancer that has come back after surgery with apalutamide and targeted radiation based on PET imaging. More here: bit.ly/indicate-trial
In our August newsletter, the co-chairs spotlight an open letter to Congress from the National Clinical Trials Network Cooperative Group Chairs, detailing its significant contributions to patient welfare. Read their editorial and the full letter here: bit.ly/41x0VO5 #CancerResearch #ClinicalTrials
September 3, 2025 at 1:36 PM
In our August newsletter, the co-chairs spotlight an open letter to Congress from the National Clinical Trials Network Cooperative Group Chairs, detailing its significant contributions to patient welfare. Read their editorial and the full letter here: bit.ly/41x0VO5 #CancerResearch #ClinicalTrials
The EA3211 clinical study is testing a potential new treatment for patients with #HeadAndNeckCancer that has spread to a limited number of places. Learn more: bit.ly/ea3211-study #hncsm
August 27, 2025 at 4:13 PM
The EA3211 clinical study is testing a potential new treatment for patients with #HeadAndNeckCancer that has spread to a limited number of places. Learn more: bit.ly/ea3211-study #hncsm
Submit an Abstract for the 2025 Young Investigator Symposium by Thursday, 9/11! 🩻
We are now accepting research abstracts from early-career investigators interested in presenting your research as part of the upcoming Fall 2025 Group Meeting. More: bit.ly/yis-fall25 #EAOnc
We are now accepting research abstracts from early-career investigators interested in presenting your research as part of the upcoming Fall 2025 Group Meeting. More: bit.ly/yis-fall25 #EAOnc
August 21, 2025 at 4:42 PM
Submit an Abstract for the 2025 Young Investigator Symposium by Thursday, 9/11! 🩻
We are now accepting research abstracts from early-career investigators interested in presenting your research as part of the upcoming Fall 2025 Group Meeting. More: bit.ly/yis-fall25 #EAOnc
We are now accepting research abstracts from early-career investigators interested in presenting your research as part of the upcoming Fall 2025 Group Meeting. More: bit.ly/yis-fall25 #EAOnc
Trial Activation: EA2234/STOPGAP II, led by Dr. Maheswari Senthil of UCI Health, is a randomized phase II/III trial of intraperitoneal paclitaxel plus systemic treatment vs systemic treatment alone in gastric carcinomatosis. More: bit.ly/ea2234-stopg... #StomachCancer
August 21, 2025 at 1:31 PM
Trial Activation: EA2234/STOPGAP II, led by Dr. Maheswari Senthil of UCI Health, is a randomized phase II/III trial of intraperitoneal paclitaxel plus systemic treatment vs systemic treatment alone in gastric carcinomatosis. More: bit.ly/ea2234-stopg... #StomachCancer
Trial Activation: EAA241, led by Dr. Amany Keruakous of @wellstarhealth.bsky.social, is a randomized phase II trial comparing daratumumab-bortezomib-dexamethasone vs cyclophosphamide-bortezomib dexamethasone in newly diagnosed #MultipleMyeloma. For more info: bit.ly/EAA241
August 12, 2025 at 2:49 PM
Trial Activation: EAA241, led by Dr. Amany Keruakous of @wellstarhealth.bsky.social, is a randomized phase II trial comparing daratumumab-bortezomib-dexamethasone vs cyclophosphamide-bortezomib dexamethasone in newly diagnosed #MultipleMyeloma. For more info: bit.ly/EAA241
ICYMI: Check out our round-up of recently published @eaonc.bsky.social and @precogonc.bsky.social research results. More here ➡️ bit.ly/july25research
#ClinicalTrials #BreastCancer #CancerControl #CancerSurvivorship #HeadandNeck #LungCancer #Melanoma
#ClinicalTrials #BreastCancer #CancerControl #CancerSurvivorship #HeadandNeck #LungCancer #Melanoma
August 5, 2025 at 3:10 PM
ICYMI: Check out our round-up of recently published @eaonc.bsky.social and @precogonc.bsky.social research results. More here ➡️ bit.ly/july25research
#ClinicalTrials #BreastCancer #CancerControl #CancerSurvivorship #HeadandNeck #LungCancer #Melanoma
#ClinicalTrials #BreastCancer #CancerControl #CancerSurvivorship #HeadandNeck #LungCancer #Melanoma
#FindingsFriday: Did you know we publish patient-friendly, 1-2 page summaries of the results of many of our #ClinicalTrials? View them here: bit.ly/trial-summar... #CancerResearch #ClinicalTrials
August 1, 2025 at 12:47 PM
#FindingsFriday: Did you know we publish patient-friendly, 1-2 page summaries of the results of many of our #ClinicalTrials? View them here: bit.ly/trial-summar... #CancerResearch #ClinicalTrials
Do you have an aggressive B-cell #Lymphoma that has either come back or persisted after initial therapy? If so, you may be eligible to participate in #ClinicalTrial EA4231. More info here: bit.ly/EA4231 #lymsm
July 22, 2025 at 5:19 PM
Do you have an aggressive B-cell #Lymphoma that has either come back or persisted after initial therapy? If so, you may be eligible to participate in #ClinicalTrial EA4231. More info here: bit.ly/EA4231 #lymsm
Read more from our co-chairs on the importance of protecting public support for biomedical research: bit.ly/3IvxNQD #CancerResearch #ClinicalTrials
July 21, 2025 at 2:12 PM
Read more from our co-chairs on the importance of protecting public support for biomedical research: bit.ly/3IvxNQD #CancerResearch #ClinicalTrials